We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CSL market cap is 144.88B. The company's latest EPS is USD 4.5401 and P/E is 66.03.
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 8.51B | 9.1B | 10.27B | 10.49B | 13.17B |
Operating Income | 2.52B | 2.72B | 3.13B | 2.93B | 3.07B |
Net Income | 1.92B | 2.1B | 2.38B | 2.25B | 2.19B |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 12.31B | 15.62B | 18.16B | 28.35B | 36.23B |
Total Liabilities | 7.06B | 9.09B | 9.78B | 13.77B | 18.41B |
Total Equity | 5.25B | 6.53B | 8.38B | 14.58B | 17.83B |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.64B | 2.49B | 3.62B | 2.63B | 2.6B |
Investing | -1.29B | -1.37B | -1.67B | -1.64B | -11.84B |
Financing | -491.5M | -642.7M | -1.4B | 7.68B | 456M |
Market Cap | 144.88B |
Price to Earnings Ratio | 66.03 |
Price to Sales Ratio | 11 |
Price to Cash Ratio | 93.59 |
Price to Book Ratio | 8.13 |
Dividend Yield | - |
Shares Outstanding | 483.25M |
Average Volume (1 week) | 580.38k |
Average Volume (1 Month) | 720.55k |
52 Week Change | 8.60% |
52 Week High | 380.01 |
52 Week Low | 0.11 |
Spread (Intraday) | 0.39 (0.13%) |
Company Name | CSL Limited |
Address |
45 poplar road melbourne, victoria 3052 |
Website | https://www.csl.com.au |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions